This first link is of no concern. A single case report of a diabetic whose diabetes got worse with no effort to eliminate other confounding variables. This sort of thing happens frequently with diabetics. Something a simple as an infection could cause the hyperglycemia in an insulin dependent diabetic like this.
The second link I hadn't seen before. This is obviously concerning. Fraud is a major problem in medical research and this has all the hallmarks of fraud. It's hard to draw any conclusions when the data is faked. The only other things I can point to that may alleviate your concern is there is the Odyssey trial which had a little bit longer follow-up period (2.8 years) and showed improvement in mortality (of course there's always the possibility that this data was faked too). Then there's post-marketing experience which hasn't identified any major issues. PCSK9 inhibitors have been used for 7 years now, which is enough time for an issue to be exposed. Vioxx being a good example, it became well known that it was causing cardiovascular issues after about 5 years of use.